Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier

化学 吡唑 线粒体 生物化学 组合化学 药理学 立体化学 生物
作者
Lingaiah Maram,Jessica M. Michael,Henry Politte,Vaishnavi S. Srirama,A Hadji,Mohammad Habibi,Meredith O. Kelly,Rita T. Brookheart,Brian N. Finck,Lamees Hegazy,Kyle S. McCommis,Bahaa Elgendy
出处
期刊:European journal of medicinal chemistry [Elsevier BV]
卷期号:283: 117150-117150 被引量:5
标识
DOI:10.1016/j.ejmech.2024.117150
摘要

Inhibition of mitochondrial pyruvate transport via the mitochondrial pyruvate carrier (MPC) has shown beneficial effects in treating metabolic diseases, certain cancers, various forms of neurodegeneration, and hair loss. These benefits arise either from the direct inhibition of mitochondrial pyruvate metabolism or from the metabolic rewiring when pyruvate entry is inhibited. However, current MPC inhibitors are either nonspecific or possess poor pharmacokinetic properties. To address this, approximately 50 pyrazole-based MPC inhibitors were synthesized to explore the structure-activity relationship for MPC inhibition, evaluated through inhibition of mitochondrial pyruvate respiration. These inhibitors were designed with increased steric hindrance around electron-deficient double bonds, allowing for refined structural modifications that reduce their potential to act as Michael acceptors. Additionally, the new MPC inhibitors directly inhibited stellate cell activation, indicating their potential as therapeutic candidates for metabolic dysfunction-associated steatohepatitis (MASH). Unlike the thiazolidinedione class of MPC inhibitors, these compounds did not activate the nuclear receptor PPARγ. Molecular modeling was conducted to explore interactions between these novel inhibitors and the MPC complex. We have identified the chemical determinants critical for MPC inhibition and successfully developed novel inhibitors that are potent, specific and possess excellent physicochemical properties, high solubility, and outstanding metabolic stability in human liver microsomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可爱的蓝胖子完成签到,获得积分10
1秒前
大时钟的应助被hin采纳,获得10
2秒前
FashionBoy的应助被无敌大裤衩采纳,获得10
2秒前
DW的应助被675675采纳,获得10
3秒前
Bella完成签到,获得积分10
3秒前
聪慧的鸣凤完成签到 ,获得积分10
4秒前
4秒前
5秒前
5秒前
lsy完成签到,获得积分10
6秒前
南宫完成签到,获得积分10
6秒前
XPR发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
YGZ完成签到,获得积分10
7秒前
8秒前
观山青完成签到,获得积分10
8秒前
chr完成签到,获得积分10
9秒前
李健的应助被XPR采纳,获得10
10秒前
xwx发布了新的文献求助10
10秒前
郑石发布了新的文献求助10
11秒前
11秒前
kljy2010发布了新的文献求助10
12秒前
13秒前
情怀的应助被路人甲采纳,获得10
13秒前
msd2phd完成签到,获得积分10
14秒前
天真山柳发布了新的文献求助10
15秒前
Crazy_Diamond的应助被ymmmjjd采纳,获得80
15秒前
但是完成签到,获得积分10
15秒前
meteor完成签到 ,获得积分10
17秒前
18秒前
19秒前
20秒前
20秒前
21秒前
慕青的应助被阿瞒采纳,获得10
22秒前
汉堡包的应助被qingtian采纳,获得10
22秒前
ZZICU完成签到,获得积分10
22秒前
laimeng完成签到 ,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181767
求助须知:如何正确求助?哪些是违规求助? 9571480
关于积分的说明 21818225
捐赠科研通 7778030
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479598